Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Cell Calcium. 2015 Apr 30;58(2):186–195. doi: 10.1016/j.ceca.2015.04.006

Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy

Victoria Kyrychenko 1,$,*, Eva Poláková 1,#,*, Radoslav Janíček 1, Natalia Shirokova 1
PMCID: PMC4501876  NIHMSID: NIHMS691134  PMID: 25975620

Abstract

Duchenne muscular dystrophy (DMD) is a progressive muscle disease with severe cardiac complications. It is believed that cellular oxidative stress and augmented Ca2+ signaling drives the development of cardiac pathology. Some mitochondrial and metabolic dysfunctions have also been reported. Here we investigate cellular mechanisms responsible for impaired mitochondrial metabolism in dystrophic cardiomyopathy at early stages of the disease. We employed electrophysiological and imaging techniques to study mitochondrial structure and function in cardiomyocytes from mdx mice, an animal model of DMD. Here we show that mitochondrial matrix was progressively oxidized in myocytes isolated from mdx mice. Moreover, an abrupt increase in workload resulted in significantly more pronounced oxidation of mitochondria in dystrophic cells. Electron micrographs revealed a gradually increased number of damaged mitochondria in mdx myocytes. Degradation in mitochondrial structure was correlated with progressive increase in mitochondrial Ca2+ sequestration and mitochondrial depolarization, despite a substantial and persistent elevation in resting cytosolic sodium levels. Treatment of mdx cells with cyclosporine A, an inhibitor of mitochondrial permeability transition pore (mPTP), shifted both resting and workload-dependent mitochondrial redox state to the levels recorded in control myocytes. It also significantly reduced workload dependent depolarization of mitochondrial membrane in dystrophic cardiomyocytes. Overall, our studies highlight age dependent deterioration of mitochondrial function in dystrophic cardiomyocytes, which seems to be associated with excessive opening of mPTP due to oxidative stress and cellular Ca2+ overload.

Keywords: Dystrophic cardiomyopathy, sodium overload, mitochondria, metabolism, oxidative stress

Graphical Abstract

graphic file with name nihms691134u1.jpg

1. Introduction

Mitochondria are the major source of energy in cardiac muscle tissue. The organelles generate ATP from metabolites through oxidative phosphorylation. Reducing agents, such as NADH and FADH2, donate electrons to the mitochondrial respiratory chain resulting in the proton electrochemical gradient across the mitochondrial membrane. The gradient is further utilized by the mitochondrial ATP synthase to produce ATP. Mitochondrial ATP generation has to respond to the increased energy demand during mechanical activity of the heart. One way to do so is to increase the rate of oxidative phosphorylation. A moderate rise in cytosolic Ca2+ concentration (e.g. during workload) results in increased mitochondrial Ca2+ concentration ([Ca2+]m) which is known to increase the activity of tricarboxylic acid cycle (TCA) dehydrogenases, thus consequently increasing ATP synthesis. However, under some pathological conditions cytosolic and subsequent mitochondrial Ca2+ overload can promote irreversible opening of the mitochondrial permeability transition pore (mPTP), loss of functional mitochondria, reduction in cellular ATP production and even cell death. Mitochondrial Ca2+ levels mostly depend on coordinated function of several mitochondrial proteins (e.g. mitochondrial Ca2+ uniporter, mitochondrial Na+-Ca2+ exchanger (NCXm) and mitochondrial Na+-H+ exchanger) and are affected by cytosolic Ca2+ and Na+ levels, pH values and redox potential (see [16] for review).

Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease. Most of the patients develop cardiomyopathy in their teens, and many of them succumb to cardiac complications [79]. The disease is caused by a genetic defect – the lack of a functional cytoskeleton protein dystrophin [10,11] and it’s phenotype exhibits numerous cellular pathological features [12,13]. Recently we reported severe oxidative stress (resulting from overexpression of sarcolemmal NAD(P)H oxidase type II (NOX2)) and augmented intracellular Ca2+ signaling in hearts of mdx mice well before clinical manifestations of the disease [1,14]. Our results indicated that enhanced intracellular Ca2+ responses to mechanical challenges are associated with an increased sensitivity of sarcoplasmic (SR) Ca2+ release channels (a.k.a. ryanodine receptors, RyRs) due to their posttranslational modifications. We concluded that RyR oxidation followed by phosphorylation, first by CaMKII and later by PKA, synergistically contribute to RyR hypersensitivity and cardiac deterioration.

There are several reports of various mitochondrial abnormalities in hearts under conditions of intracellular Ca2+ overload and oxidative stress [10,15,16]. There is also increasing evidence of mitochondrial dysfunction in skeletal and cardiac muscle of DMD patients and mdx mice. In particular, there are indications of impaired oxidative phosphorylation, decreased ATP-generating capacity, premature stress-induced mPTP opening and mitochondrial depolarization [9,10,1723]. Some of these features are present in dystrophic hearts at early stages of the disease. However, findings from different groups of investigators are somewhat controversial and causal links between pathophysiological manifestations of dystrophy in various intracellular compartments remain unclear.

The aim of this study was to establish cellular pathophysiological mechanisms leading to deterioration of mitochondria function and energy deprivation of dystrophic heart. For this, cytosolic and mitochondrial functions were assessed in cardiac myocytes isolated from mdx mice of different age groups. These studies were complemented by analyses of mitochondrial structure with transmission electron microscopy. Our results indicate an age dependent gradual degeneration of mitochondrial structure and function in dystrophic cardiomyocytes isolated from hearts that don’t yet exhibit any sign of disease. They also suggest that mitochondrial dysfunctions are associated with increased activity of mPTP due to oxidative stress and cellular Ca2+ overload. Our results suggest that therapies targeting the mPTP may be helpful to DMD patients and improve not only skeletal muscle [21] but also cardiac performance. Some preliminary data of our study were reported in [24].

2. Materials and Methods

2.1. Cell isolation

All experiments conformed to the NIH Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication, 8th edition, 2011) and were approved by the Institutional Animal Care and Use Committee of the New Jersey Medical School, Rutgers University, USA. Mice used were C57BL10 mice (wild-type, WT, purchased from Harlan laboratory) and dystrophin-deficient mdx (C57BL/10ScSn-mdx, purchased from the Jackson Laboratory). Mice at the age of 1 (young) and 3–4 (adult) were used in this study. Ventricular myocytes were isolated enzymatically. Mice were heparinized (5000 U/kg), anesthetized with sodium pentobarbital (100 mg/kg), and checked to ensure the absence of movement, flexor, and pedal reflexes. Hearts were removed, mounted on a Langendorff apparatus and perfused with zero Ca2+ Tyrode solution containing collagenase and protease or Liberase. Ventricles were cut into small pieces from which cells were mechanically dissociated and transferred to fresh solution followed by stepwise increasing Ca2+ concentration to 200 μM. Solution was changed to 1.8 mM CaCl2 containing Tyrode solution shortly before each experiment. All experiments were carried out at room temperature and cells were used within 5 h after isolation. Solutions: Zero Ca2+ Tyrode (in mM): 140 NaCl, 5.4 KCl, 1.1 MgCl2, 5 HEPES, 1 NaH2PO4, 10 glucose, pH 7.3, 300 mOsm. Normal Tyrode (NT) (in mM): 1.8 CaCl, 140 NaCl, 5.4 KCl, 1.1 MgCl2, 5 HEPES, 1 NaH2PO4, 10 glucose, pH 7.4, 300 mOsm.

2.2. NADH measurement

NADH autofluorescence from the regions corresponding to mitochondria was measured with 2-photon confocal microscopy (Bio-Rad-2002-MP) in frame scanning mode at 0.1 Hz illuminations, using 720 nm excitation wavelength of the Mira-Verdi laser duo (Coherent, USA). After experimental manipulation, the resting NADH level in cells perfused with NT solution was calibrated. Maximal oxidation of NADH (a.k.a. 0% reduced NADH signal) was achieved by superfusing cells with NT solution supplemented with 1 μM FCCP and 1 μg/ml oligomycin. Maximal reduction (a.k.a. 100% reduced NADH signal) was achieved by superfusing myocytes with NT supplemented with 5 μM rotenone and 10 mM β-hydroxybutyric acid. Resting NADH level was calculated and expressed as percentage of reduced NADH value for each cell, as in [3].

2.3. Electron microscopy

Hearts were removed, fixed with paraformaldehyde, sliced and imaged with a Phillips CM12 transmission electron microscope at Rutgers Core Imaging Lab.

2.4. Intracellular Na+ calibration

Intracellular Na+ signals ([Na+]i) were measured using either SBFI (10 μM SBFI-AM, 90 mins) or Asante NaTRIUM Green-2 (2 μM, 30 min) indicators. RatioMaster M-40 photometer (PTI, USA) was used to monitor the Na+-related SBFI fluorescence. Cells were sequentially illuminated at 340 and 380 nm at 1 Hz. Emitted light was collected above 500 nm and presented as excitation ratio. Changes in Asante NaTRIUM were recorded with confocal microscopy (Bio-Rad Radiance 2002MP) with the 488 nm excitation line of an Argon laser. After measurement of SBFI or Asante NaTRIUM Green-2 fluorescent intensity signals at resting conditions (cells perfused with NT), a calibration procedure was performed. For this, the perfusion solution was changed to Na+ free solution followed by stepwise increases of extracellular Na+ concentration (10, 20, 30, 50, 100, 145 mM). Resting [Na]i for each cell was taken from the corresponding calibration curve. Na+ calibration solutions: 145 mM K+ solution (in mM): 135 K-gluconate, 10 KCl, 10 HEPES, 2 EGTA, 0.01 Ouabain, 0.01 Monensin, 0.01 Nigericin, 0.01 Gramicidin, 10 Glucose, pH 7.4, 300 mOsm.145 mM Na+ solution (in mM): 135 Na-gluconate, 10 NaCl, 10 HEPES, 2 EGTA, 0.01 Ouabain, 0.01 Monensin, 0.01 Nigericin, 0.01 Gramicidin, 10 Glucose, pH 7.4, 300 mOsm. Mixtures of 145 mM K+ and 145 mM Na+ solution solutions in different proportions were used to reach required Na+ concentrations.

2.5. Measurements of mitochondrial Ca2+ content

Cells were loaded with cytosolic Ca2+ indicator fluo-4 (5 μM, 30 min). Changes in fluo-4 Ca2+ related fluorescence were recorded with an Olympus (FluoView-1000) confocal microscope using the 473 nm excitation of a diode laser. 2 μM FCCP and 1 μg/ml oligomycin was added to promote mitochondrial Ca2+ efflux to the cytosol. To minimize contribution of Ca2+-induced Ca2+ release from the SR, cells were pretreated with 10 μM ryanodine and 1 μM thapsigargin and field stimulated. The amplitude of FCCP-induced Ca2+ signal was used to evaluate mitochondrial Ca2+ content.

2.6. Mitochondrial membrane potential and mPTP opening

TMRE indicator (100 nM) was used to monitor mitochondrial membrane potential. TMRE fluorescence was measured with an Olympus (FluoView-1000) confocal microscope using the 559 nm excitation of a diode laser. 2 μM FCCP and 1 μg/ml oligomycin were applied to completely depolarize mitochondria. The application resulted in redistribution of the indicator between mitochondria, cytosol and nuclei. To distinguish between cytosolic and mitochondrial signals, nuclear fluorescence (that is assumed to be the same as cytosolic) was subtracted from the fluorescence of cytosolic regions of cells that also included mitochondria. The opening of mPTP was monitored using fluorescent molecule calcein (473 nm excitation), which enter mitochondria after mPTP induction.

2.7. Statistics

Results are shown as mean ± standard error (SEM). All data sets contain results from a minimum of three mice. Statistical significance was evaluated by non-paired t-test or two-way ANOVA test. A p-value of < 0.05 was considered significant.

3. Results

To establish causal relationship between cytosolic and mitochondrial pathophysiological pathways in cardiac dystrophy, we analyzed several cytosolic and mitochondrial signals: cytosolic Ca2+ (determined in our previous work [10]) and Na+ concentrations, cellular redox state (determined by us in [14]), mitochondrial redox state, mitochondrial Ca2+ content and mitochondrial membrane potential. To follow the progression of this relationship at preclinical stages of the dystrophic cardiomyopathy, signals were monitored in cells isolated from young (1 month) and adult (3–4 months) WT and mdx mice, which do not show any sign of cardiac pathology. Functional studies were supplemented by the analysis of mitochondrial morphology assessed with transmission electron microscopy.

3.1. Mitochondrial matrix is oxidized in dystrophic cardiac myocytes

In order to obtain some insight into mitochondrial function in cells isolated from dystrophic and WT cells, we assessed the mitochondrial redox state of NADH/NAD+ by measuring and calibrating NADH autofluorescence using 2 photon confocal system. Fig. 1A illustrates the experimental procedure. We recorded the NADH signal at rest (baseline) and subsequently under fully oxidized or reduced conditions, as detailed in methods. Images at the bottom show NADH signals in WT cell in completely oxidized or reduced settings. The baseline level of NADH autofluorescence was expressed as a percentage of the reduced value. The redox state of mitochondrial NADH/NAD+ couple was substantially more oxidized in the mdx myocyte, compared to WT cell (32% vs. 51% of reduction, respectively). Fig. 1B summarizes our findings: the redox state of NADH/NAD+ is significantly more oxidized in dystrophic myocytes (26.7±2.7% (n=10) and 25.2±2.7% (n=21) in cells from young and adults hearts, respectively, vs. 42.7±2.7% (n=5) and 42.6±2.3% (n=28) in myocytes from young and adult WT mice, respectively).

Fig. 1.

Fig. 1

Mitochondrial matrix is more oxidized in dystrophic cardiomyocytes. (A) Representative traces of averaged NADH autofluorescence acquired during the calibration procedure in cells from WT and mdx ventricles. At the bottom are typical images of a myocyte after complete reduction and oxidation of mitochondria matrix. (B) Averaged resting values of NADH pooled out from cardiomyocytes isolated from WT and mdx mice of different age groups, as indicated. Data are from young (n=5) and adult (n=12) WT and young (n=11), adult (n=15) mdx myocytes. (*p < 0.05). (C) Changes in NADH signals during increased workload in WT and mdx cells. Calibration procedure was applied to each cell at the end of experiment. Protocol is indicated at the top. (D) Averaged values of NADH levels at three time points: under resting conditions, after 1 min of isoproterenol application and after 5 min of 4Hz stimulation in the presence of the same concentration of isoproterenol. Data are from young (n=5) and adult (n=7) WT and young (n=10) and adult (n=10) mdx myocytes. (*p < 0.05).

In the next group of experiments, we tested the effects of increasing metabolic workload on the redox state of NADH/NAD+ couple. For this, cells were paced at 4Hz in the presence of 0.1 mM isoproterenol (Fig. 1C). An abrupt increase in workload resulted in oxidation of NADH both in mdx and WT cardiomyocytes. However, the extent of oxidation was significantly greater in dystrophic cells, especially in those isolated from adult animals. NADH signal decreased from 30.5±2.7 % at the baseline to 16.3±3.1% (n=10) at the end of the stimulation protocol in mdx cells from adult animals, whereas it reduced from 46.6±2.2% to 36.7±0.9% (n=7) in adult WT cells. When workload was discontinued, the mitochondrial matrix NADH quickly returned to baseline levels in WT but not always in mdx cells. Moreover, as the age of mdx animals increased, oxidation of mitochondrial matrix during transitions of workload became more pronounced (Fig. 1D).

3.2. Mitochondria morphology is abnormal in dystrophic cardiac myocytes

Next we aimed to determine if and to what extent deregulation of mitochondrial function in dystrophic cardiac tissue correlates with mitochondrial structural abnormalities. For this, sections of WT and mdx cardiac muscle were imaged with transmission electron microscopy (Fig. 2A). Electron micrographs revealed numerous mitochondria with increased area in mdx cardiac muscle, and many mitochondria with a loss of normal cristae structure (indicated by arrowheads). Figs. 2B and C quantify these observations. The number of mitochondria with a loss of cristae, as well as the average area of mitochondria was significantly higher in mdx cardiac myocytes. Moreover, the number of structurally abnormal mitochondria increased in cardiac tissue isolated from adult dystrophic animals, which parallels the worsening of mitochondrial function described above.

Fig. 2.

Fig. 2

Abnormal mitochondrial morphology in dystrophic cardiomyocytes. (A) Typical transmission electron micrographs of heart slices from adult WT and mdx mice. Arrows indicate mitochondria with a loss of cristae. Scale bar corresponds to 500 nm. (B) Percent of defective mitochondria. 18–20 random fields with 50 to 110 mitochondria were analyzed in each experimental group. (C) Summary of mitochondria area in hearts from young and adult WT and mdx mice. 122 to 244 mitochondria from at least 7 different fields were analyzed in each group. Samples from two hearts were analyzed in each experimental cluster. (*p < 0.05, #p < 0.001).

3.3. Intracellular [Na+] is elevated in dystrophic hearts

Previously we have shown that dystrophin-deficient cardiomyocytes, which are characterized by a fragile and leaky plasma membrane, have increased ion influx through several trans-membrane pathways in response to mechanical stretch [25]. A major component of this influx was proposed to be composed of Na+ ions. We assumed that enhanced Na+ influx eventually results in cellular Na+ overload, which in turn can influence mitochondrial function [1,3,4]. In particular, increased [Na+]i may accelerate mitochondrial Ca2+ efflux and decrease mitochondrial Ca2+ accumulation, resulting from the larger Na+ gradient across the mitochondria and thus stimulation of mitochondrial NCX. The subsequent decrease in [Ca2+]m may hamper the activation of mitochondrial TCA dehydrogenases, which in turn can affect the mitochondrial metabolic state and cause a pronounced NADH oxidation. However, the elevated cytosolic Na+ concentration may also cause additional Ca2+ influx via sarcolemmal NCX, which could partly or completely counteract the improved mitochondrial Ca2+ removal.

Cells were loaded with either of two fluorescent Na+ indicators, SBFI or Asante NaTRIUM, and studied either with fluorescent photometry or confocal microscopy. Calibration was performed by superfusing cells with solutions containing various Na+ concentrations, as described in Methods. Fig. 3A illustrates typical experiments with cardiomyocytes isolated from adult WT (top panels) or mdx (low panels) mice. First, we measured F340/F380 ratio in intact cells under resting conditions. Then calibration procedure was applied. The SBFI ratio signal increased with increasing [Na+] in the superfusing solutions (left traces in Fig. 3A). Left traces are calibration curves obtained in these cells. Please note that while at lower Na+ concentration calibration curves were linear, they become saturated at higher Na+ levels. The calibration procedure revealed resting [Na+]i values of 10.2 and 18.5 mM in these particular WT and dystrophic cardiomyocytes, indicating markedly elevated cytosolic Na+ levels in dystrophic hearts.

Fig. 3.

Fig. 3

Intracellular [Na+] is elevated in mdx cardiomyocytes. (A) Calibration of intracellular [Na+]. Representative traces of SBFI fluorescence acquired during calibration procedures in cells from WT and mdx adult hearts. (B) Averaged values of intracellular [Na+] in cardiomyocytes isolated from WT and mdx mice of different age groups, as indicated. (*p< 0.05, #p < 0.001). Data are from young (n=6) and adult (n=11) WT and young (n=8) and adult (n=7) mdx myocytes. (*p < 0.05).

The results with both Na+-sensitive indicators were similar, so data were pooled together and averaged (Fig. 3B). The averaged values of resting [Na+]i were significantly elevated in myocytes isolated from mdx mice in two age groups studied (18.3±1.4 (n=8), 24.4±3.1(n=11) vs. 12.4±1.6(n=6), 14.0±1.7(n=9) in dystrophic and WT cells from young and adult mice, respectively). Overall, dystrophic cardiomyocytes are overloaded with Na+. Whether or not this is the underlying reason for oxidation of mitochondrial matrix NADH was examined in the next group of experiments.

3.4. Mitochondrial Ca2+ content is increased in dystrophic hearts

As discussed above, the direct consequence of intracellular Na+ overload could be an acceleration of mitochondrial Ca2+ extrusion. If this would be the case, it could consequently lead to an oxidation of the mitochondrial matrix NADH. Nevertheless, there are several reports of elevated Ca2+ content in mitochondrial of dystrophic skeletal and cardiac muscle [7,9]. In these experiments, we wanted to confirm that this is the case under our experimental conditions. The direct measurements of mitochondrial Ca2+ concentration in intact cells with conventional (non-genetically targeted) fluorescent indicators (e.g. rhod-2) is challenging, as large portions of the dye remain trapped in the cytosol obscuring the mitochondrial measurements. Therefore here we applied an indirect method. Like many other methods it has multiple pros and cons. The major advantage is technical simplicity. The major disadvantage is the specificity of intracellular targeting of fluorescent indicator. We evaluated the amount of Ca2+ released from the mitochondria after depolarization of the mitochondrial membrane. The contribution of CICR was minimized by pretreatment of cells with ryanodine and thapsigargin and pre-pacing. Cells were loaded with the cytosolic calcium indicator fluo-4. Our control experiments revealed slight decrease in fluo-4 signal after application of inhibitor of mitochondrial NCX CGP37157, indicating cytosolic targeting of fluo-4, as CGP37157 is known to increase mitochondrial and decrease cytosolic Ca2+ levels. Cells were superfused with extracellular solution supplemented with mitochondrial uncoupler FCCP in combination with oligomycin. Application of FCCP led to a significant increase in intracellular Ca2+ concentration (Fig. 4A). The amplitudes of FCCP-induced Ca2+ transients were associated with mitochondrial Ca2+ load. The amplitudes were not much different in cells from young animals (1.21±0.02 (n=25) and 1.20±0.03 (n=18) F/F0 in WT and dystrophic cells, respectively) but were significantly greater in cardiomyocytes isolated from hearts of adult mdx mice (1.30±0.03 (n=19) and 1.51±0.09 (n=23) F/F0, Figure 4B). Importantly, these findings were in good agreement with the previously observed cellular Ca2+ overload found in adult but not young mdx myocytes [10]. It should be mentioned that we, and others, have previously reported slightly elevated cytosolic Ca2+ levels in adult mdx myocytes compared to WT cells (~20 nM, or less than 0.1 F/F0) [10,16]. However, this difference is not substantial enough to significantly influence the results described above.

Fig. 4.

Fig. 4

Mitochondrial Ca2+ is elevated in adult mdx cardiomyocytes. (A) Typical traces of Fluo-4 fluorescence in adult WT and mdx cardiomyocytes during treatment with FCCP and oligomycin. (B) Average changes in cytosolic Ca2+ levels after FCCP application. (*p < 0.05). Data are from young (n=25) and adult (n=19) WT and young (n=18) and adult (n=23) mdx myocytes. (*p < 0.05).

Overall, our data supports previous finding by others that the mitochondrial Ca2+ levels are elevated in hearts of adult mdx mice. Therefore, elevated Na+ levels cannot explain the oxidation of mitochondrial NADH/NAD+ redox couple in a straightforward way. With the next experiments we tested for the alternative mechanisms.

3.5. Mitochondrial membrane is depolarized in dystrophic hearts

Several major and primary features of the cellular phenotype of cardiac dystrophy at early, preclinical stages of the disease result from severe oxidative stress, mostly due to overexpression of NOX2 and consequent posttranslational modification (oxidation and CaMKII phosphorylation) of Ca2+ release channels. As disease progresses, intracellular Ca2+ homeostasis gets more deregulated due to synergetic activation of additional mechanisms that contribute to increased sensitivity of RyRs [12]. Altogether the enhanced Ca2+ signals eventually lead to cytosolic and mitochondrial Ca2+ overload. These pathological conditions are some of key factors responsible for excessive opening of the mitochondrial permeability transition pore (mPTP). Prolonged opening of the pore leads to mitochondrial depolarization and dissipations of the proton gradient responsible for oxidative phosphorylation and ATP synthesis. Another consequence of mPTP opening is mitochondrial swelling and rupture owing to the sudden influx of water and solutes. Micrographs in Fig. 2 indicate swollen mitochondria in mdx but not in WT cardiac tissue. Here we tested whether the mitochondrial membrane potential (ψm) is changed in dystrophic cardiomyocytes.

Cells were loaded with the mitochondrial membrane potential sensitive indicator TMRE. The intensity of TMRE signal was recorded at resting conditions and then then during application of FCCP with oligomycin. The signal after application of FCCP was assumed to originate from completely depolarized mitochondria. It was used to calibrate the TMRE signal under resting conditions. Dissipation of Δψm resulted in redistribution (and equilibration) of the indicator between mitochondrial matrix and cytosol. Therefore the TMRE signal from the nuclei was subtracted from the mixed (cytosolic and mitochondrial) signal to correct for cytosolic TMRE contamination. Our data indicate that mitochondrial membrane is more depolarized in cells from mdx compared to WT mice but the difference was significantly larger only in cells from adult animals (in a.u. 614±75 (n=9) vs. 576±54 (n=8) and 517±44 (n=6) vs 407±22 (n=6) in myocytes from young and adult WT and mdx mice, respectively). This corresponds to a 6% and 20% greater TMRE signal in cells from young and adult WT mice compared to their dystrophic counterparts.

The greater extent of depolarization of mitochondrial membrane in mdx cardiomyocytes as well as larger number of swollen mitochondria (see Fig. 2) suggests excessive opening of mPTP in dystrophic hearts, which becomes exaggerated as disease progresses.

3.6. Inhibition of mPTP in dystrophic myocytes minimized oxidation of mitochondrial matrix during workload

Our results described above suggest that premature and excessive opening of mPTP, probably due to cellular oxidative stress and Ca2+ overload, results in dissipation of the proton gradient, inhibition of oxidative phosphorylation and oxidation of mitochondrial NADH/NAD+ couple. Here we directly test whether inhibition of mPTP minimizes oxidation of the mitochondrial matrix NADH pool and prevents ATP deprivation in dystrophic hearts.

Fig. 6 summarizes the experiments in which we evaluated the ability of the NADH/NAD+ redox couple to cope with an increased metabolic workload imposed on cardiomyocytes isolated from adult mice (as in Fig. 1C) in the presence of the mPTP inhibitor Cyclosporin A (1 μM). Treatment of dystrophic cells with Cyclosporin A normalized the mitochondrial redox state in adult dystrophic cardiomyocytes after increased workload.

Fig. 6.

Fig. 6

Oxidation of mitochondrial matrix in mdx cardiomyocytes is prevented by inhibition of mPTP. Averaged values of NADH signals at three time points: under resting conditions, after 1 min of isoproterenol application and after 5 min of 4Hz stimulation in the presence of isoproperenol. Data was acquired from adult WT (n=12) and mdx cardiomyocytes without (n=10) and with (n=7) treatment with cyclosporine A.

3.7. Inhibition of mPTP in dystrophic myocytes reduced loss of mitochondrial membrane potential during workload

Opening of mPTP is usually associated with the loss of mitochondrial membrane potential. In order to obtain more support for our hypothesis implying involvement of mPTP in impaired mitochondrial metabolism, we tested 1) whether the mitochondrial membrane potential dissipates in mdx cardiomyocytes in response to increased workload and 2) whether treatment of dystrophic cells with Cyclosporin A counteracts the loss of ψm.

Fig. 7A shows representative images of TMRE fluorescence collected from two different mdx cells subjected to the workload protocol used before. As in experiments shown in Fig. 1C, cells were paced at 4Hz in the presence of 0.1 μM isoproterenol. Some mitochondria in resting mdx cells seemed to be already depolarized (no TMRE signal recorded). It should be also noted that the extent of ψm loss during the stimulation protocol significantly varied. Whereas some mdx cells lost only few to several dozen functional mitochondria (n=9, typical images are shown in Fig. 7A, top panels), others lost a significantly larger number of them or even all of the organelles (n=3, images are in Fig. 7A bottom). We suggested that the loss of TMRE fluorescence in individual mitochondria is associated with mPTP opening.

Fig. 7.

Fig. 7

Dissipation of mitochondrial membrane potential in mdx cardiomyocytes is diminished by inhibition of mPTP. (A) Representative images of mdx cardiomyocytes with different extent of depolarized mitochondrial. Scale bar corresponds to 20 μm. (B) Images of mdx cell dual-loaded with TMRE (inside mitochondria) and calcein-AM (localized to the sytosol). Graphs on the left show that cytosolic calcein enters mitochondrion after mPTP induction. (C) Averaged values of TMRE signals at five time points (indicated by * in panel B): under resting conditions, after 1 min of isoproterenol application, after 5 min of 4Hz stimulation, after following 30 s of isoproterenol application and after following washout in WT (n=9) and mdx cells with (n=8) and without (n=9) treatment with Cyclosporin A. (D) Fraction of mitochondria completely depolarized in three groups of cells during stimulation protocol. There is a significant difference in % of loss between WT and mdx at the end of stimulation protocol.

In the next group of experiments cells were loaded with two fluorescent indicators: TMRE and calcein. These two fluorescent markers have well separated excitation/emission properties and can be monitored simultaneously. The neutral fluorescent molecule calcein is often used to visualize mPTP openings. It readily enters mitochondria only after mPTP induction. Images on Fig. 7B illustrate accumulation of calcein (bottom panels) in mitochondria that irreversibly lost their membrane potential after the stimulation protocol (top panels). Graphs on the left show time course of TMRE and calcein signals in four selected mitochondria marked on the images by boxes. It is evident that depolarization of mitochondrial membrane was immediately followed by accumulation of calcein, confirming mPTP opening.

Figs. 7C and 7D summarize data illustrated in Fig. 7A. An increase in workload resulted in a gradual depolarization of mitochondrial membrane both in WT and mdx cells (Fig. 7). However, depolarization was stronger in dystrophic cardiomyocytes. Treatment of mdx cells with Cyclosporin A prevented loss of ψm in mdx cells to some extent. On average, the TMRE signal decreased by 3%±0.08% (n=9), 9%±4.7% (n=9) and 4%±1.4% (n=8) by the end of the stimulation protocol in WT, mdx and mdx treated with Cyclosporine A cells, respectively. Unfortunately, the significance of these results could not be established due to wide variability of the responses in the adult mdx cells.

Fig. 7D represents the fraction of depolarized mitochondria after increased workload in three groups of experiments. The loss of functional mitochondria was significantly greater in mdx cells, compared to WT and treated mdx myocytes. The treatment of mdx cardiomyocytes with Cyclosporine A substantially reduced the loss.

4. Discussion

In the present study we have defined changes in mitochondrial function during the development of cardiac dystrophy. Our experiments revealed that the mitochondrial matrix NADH/NAD+ redox couple is oxidized in cardiac muscle of mdx mice, well before the clinical onset of cardiac myopathy. In addition, the ability of dystrophic hearts to cope with increased metabolic workload is impaired. In parallel, we also found that the cytosol of dystrophic cardiomyocytes is overloaded with Na+. Therefore we first though that oxidation of the mitochondrial matrix is a result of increased cytosolic Na+ level. As it was shown before [1], increased [Na+]i could decrease Ca2+ sequestration in the mitochondria by stimulating Ca2+ efflux via mitochondrial Na+-Ca2+ exchanger, consequently reduce the activity of several enzymes of the mitochondrial respiratory chain and therefore shifting the redox status of NADH/NAD+ couple towards oxidation.

However, this conjecture was not supported by our experimental results. No significant difference in both cytosolic [10,16] and mitochondrial Ca2+ load was observed in myocytes isolated from young animals, despite increased cytosolic Na+ level. Moreover, as the disease progresses, the cytosol got steadily overloaded with Ca2+. It was accompanied by the increase in mitochondrial Ca2+ sequestration, gradual depolarization of mitochondrial membrane as well as by changes in mitochondrial morphology: many organelles appeared swollen and lost cristae.

The apparent contradiction between Na+ and Ca2+ handing in dystrophic cardiomyocytes, at least in part, could be explained assuming that mitochondrial Na+ influx and efflux pathways (NCXm and Na+-H+ antiporter) are altered in dystrophy. Previous findings by others and us revealed that dystrophic hearts are under severe oxidative stress, even at preclinical stages of the disease. Increased expression and/or activity of sarcolemmal NOX2 were affirmed to be responsible for this phenomenon [10,17,20]. Oxidative stress in dystrophic cells can inhibit NCXm [2,46,26,27] and reduce extrusion of Ca2+ from mitochondria. Another possibility is that elevated [Na+]i could provoke acidification of the cytosol and consequently increase Na+ extrusion from the mitochondria, thus promoting their Ca2+ accumulation [8,28]. Nevertheless, this does not explain the oxidation of mitochondrial NADH/NAD+ system found in our experiments.

In dystrophic hearts, the oxidation of intracellular environment triggers a chain of events that leads to sensitization of RyRs, exaggerated intracellular Ca2+ signaling and eventually results in an increase in cytosolic Ca2+ levels. In addition, oxidation of the intracellular environment enhances Ca2+ influx through the sarcoplasmic membrane via several pathways (e.g. stretch-activated channels and membrane ruptures [11,25]), which may also contribute to cytosolic and consequently mitochondrial Ca2+ overload, mitochondrial depolarization and oxidation of NADH/NAD+ redox couple. Further, CaMKII was found to become activated by oxidative stress during dystrophy [13,14,29] which would further amplify several Ca2+ signaling pathways via modulation of channels and transporters (e.g. RyR2s [14,30]).

However, we and others observed no increase in [Ca2+]i at the onset of dystrophy [10,15], suggesting that Ca2+ extrusion mechanisms are capable to counteract the increased Ca2+ influx into the cytosol. Similarly no increase in the mitochondrial Ca2+ level was recorded. Nevertheless, some functional and structural changes in the organelles were already detectable (Figs. 1 and 2). Hence, it appears that mitochondrial dysfunctions at this stage of disease are independent of mitochondrial Ca2+ overload. E.g. in response to cytosolic oxidative stress the distribution of NADH between cytosol and mitochondria can be shifted to compensate for oxidation of the cytosol thus shifting the mitochondrial NADH/NAD+ redox potential. In addition, excessive H2O2 (resulting from conversion of superoxide, produced by NOX2) in the cytosol can easily cross mitochondrial membrane to react with glutathione peroxidase and thus also contribute to oxidation of NADH pool.

At later stages of the disease, the oxidation of the cytosol becomes stronger, sensitization of RyRs due to additional post-translational modifications becomes greater, and Ca2+ leak from the SR increases [9,10,14,18,19,2123]. The latter results in a significant increase in cytosolic [10,21] and mitochondrial [9,24] Ca2+ levels. It seems that at this time point, severe cellular oxidative stress and Ca2+ overload promote opening of mPTP leading to an impairment of oxidative phosphorylation and ATP synthesis.

Under normal physiological conditions, mitochondria use electron transport through the respiratory chain to generate an electrochemical gradient across the inner mitochondrial membrane. This gradient, which consists of a membrane potential and a proton gradient, is used by the ATP-synthase to phosphorylate ADP to ATP. Under pathological conditions, however, widespread opening of mPTP results in depolarization of the mitochondrial membrane, dissipation of the proton gradient consequently reversing the operation of ATP-synthase to the point where it consumes ATP instead of producing it. This, in turn, facilitates cell death by apoptotic or necrotic mechanisms.

In fact, excessive opening of mPTP, as well as its premature opening in response to stress, has been attributed to a wide range of cardiac diseases [3,15,31]. Various structural, biochemical and functional mitochondrial abnormalities have been reported for dystrophic skeletal and cardiac muscle [10,32,33]. Among them is a predisposition of mitochondria from mdx hearts to an increased propensity of mPTP opening during ischemia-reperfusion [14,22]. Our results show that during the progression of dystrophic cardiac myopathy there is an accumulation of dysfunctional mitochondria. Gradual increase in oxidative stress and rise in cytosolic Ca2+ levels favor the irreversible opening of mPTP, which culminates in cellular death and loss of cardiac tissue, contributing to muscle fibrosis. Showing significant mitochondrial involvement in the pathology of dystrophy our data also provide additional support to the possibility for the mPTP to be a possible pharmacological target for treatment of the disease [25,34].

Fig. 5.

Fig. 5

Mitochondrial membrane is partially depolarized in adult mdx cardiomyocytes. (A) Representative images and time-course of TMRE fluorescence in adult WT cardiomyocytes during calibration procedure. Arrowheads indicate nuclei, from which extra-mitochondrial TMRE fluorescence was collected. Signals were recorded from cytosolic part, containing mitochondria and from nucleus. The difference in fluorescence between cytosolic and nucleus regions corresponds to mitochondria-derived signal. Scale bar corresponds to 15 μm. (B) The averaged changes in TMRE signals in young and adult WT and mdx cardiomyocytes after treatment with FCCP and oligomycin. (*p < 0.05). Data are from young (n=9) and adult (n=6) WT and young (n=8) and adult (n=6) mdx myocytes. (*p < 0.05).

Research Highlights.

  • Duchenne muscular dystrophy (DMD) is a progressive muscle disease with severe cardiac pathology.

  • We show that mitochondrial function and structure progressively deteriorate in this disease.

  • It is likely associated with excessive openings of mPTP due to oxidative stress and cellular Ca2+ overload.

Acknowledgments

Funding

This work was supported by NIH (HL093342 and AR053933 to N.Sh.). Eva Polakova was recipient of a Postdoctoral Fellowship from AHA. We are grateful to Drs. L. Gaspers, E. Niggli and A.P. Thomas for useful comments on this project.

Footnotes

Conflict of interest: none declared

*

Co-author Approval Statement

The manuscript, or part of it, has neither been published nor is currently under consideration for publication by any other journal. The co-authors have read the manuscript and approved this submission. Authors have no conflict of interests.

*

Conflict of Interest Statement

The manuscript, or part of it, has neither been published nor is currently under consideration for publication by any other journal. The co-authors have read the manuscript and approved this submission. Authors have no conflict of interests.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Maack C, Cortassa S, Aon MA, Ganesan AN, Liu T, O’Rourke B. Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ Res. 2006;99:172–182. doi: 10.1161/01.RES.0000232546.92777.05. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Williams GSB, Boyman L, Lederer WJ. Mitochondrial calcium and the regulation of metabolism in the heart. J Mol Cell Cardiol. 2014 doi: 10.1016/j.yjmcc.2014.10.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kohlhaas M, Liu T, Knopp A, Zeller T, Ong MF, Böhm M, et al. Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation. 2010;121:1606–1613. doi: 10.1161/CIRCULATIONAHA.109.914911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bay J, Kohlhaas M, Maack C. Intracellular Na+ and cardiac metabolism. J Mol Cell Cardiol. 2013 doi: 10.1016/j.yjmcc.2013.05.010. [DOI] [PubMed] [Google Scholar]
  • 5.Dedkova EN, Blatter LA. Calcium signaling in cardiac mitochondria. J Mol Cell Cardiol. 2013;58:125–133. doi: 10.1016/j.yjmcc.2012.12.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Eisner V, Csordás G, Hajnóczky G. Interactions between sarco-endoplasmic reticulum and mitochondria in cardiac and skeletal muscle - pivotal roles in Ca2+ and reactive oxygen species signaling. J Cell Sci. 2013;126:2965–2978. doi: 10.1242/jcs.093609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Shkryl VM, Martins AS, Ullrich ND, Nowycky MC, Niggli E, Shirokova N. Reciprocal amplification of ROS and Ca2+ signals in stressed mdx dystrophic skeletal muscle fibers. Pflugers Arch. 2009;458:915–928. doi: 10.1007/s00424-009-0670-2. [DOI] [PubMed] [Google Scholar]
  • 8.Finsterer J, Stöllberger C. The heart in human dystrophinopathies. Cardiology. 2003;99:1–19. doi: 10.1159/000068446. [DOI] [PubMed] [Google Scholar]
  • 9.Viola HM, Davies SMK, Filipovska A, Hool LC. L-type Ca2+ channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte. Am J Physiol Heart Circ Physiol. 2013;304:H767–H775. doi: 10.1152/ajpheart.00700.2012. [DOI] [PubMed] [Google Scholar]
  • 10.Jung C, Martins AS, Niggli E, Shirokova N. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc Res. 2007;77:766–773. doi: 10.1093/cvr/cvm089. [DOI] [PubMed] [Google Scholar]
  • 11.Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993;122:809–823. doi: 10.1083/jcb.122.4.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Niggli E, Ullrich ND, Gutierrez D, Kyrychenko S, Poláková E, Shirokova N. Posttranslational modifications of cardiac ryanodine receptors: Ca2+ signaling and EC-coupling. Biochimica Et Biophysica Acta (BBA) - Molecular Cell Research. 2012 doi: 10.1016/j.bbamcr.2012.08.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Shirokova N, Niggli E. Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies. J Mol Cell Cardiol. 2013;58:217–224. doi: 10.1016/j.yjmcc.2012.12.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kyrychenko S, Polakova E, Kang C, Pocsai K, Ullrich ND, Niggli E, et al. Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. Cardiovasc Res. 2013;97:666–675. doi: 10.1093/cvr/cvs425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lisa FD, Canton M, Menabò R, Kaludercic N, Bernardi P. Mitochondria and cardioprotection. Heart Fail Rev. 2007;12:249–260. doi: 10.1007/s10741-007-9028-z. [DOI] [PubMed] [Google Scholar]
  • 16.Williams IA, Allen DG. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol. 2006;292:H846–H855. doi: 10.1152/ajpheart.00688.2006. [DOI] [PubMed] [Google Scholar]
  • 17.Williams IA, Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol. 2007;293:H1969–H1977. doi: 10.1152/ajpheart.00489.2007. [DOI] [PubMed] [Google Scholar]
  • 18.Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K, Kunz WS. Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem. 1998;183:87–96. doi: 10.1023/a:1006868130002. [DOI] [PubMed] [Google Scholar]
  • 19.Robert V. Alteration in Calcium Handling at the Subcellular Level in mdx Myotubes. Journal of Biological Chemistry. 2000;276:4647–4651. doi: 10.1074/jbc.M006337200. [DOI] [PubMed] [Google Scholar]
  • 20.Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: rapid mechano-chemo transduction in heart. Science. 2011;333:1440–1445. doi: 10.1126/science.1202768. [DOI] [PubMed] [Google Scholar]
  • 21.Reutenauer J, Dorchies OM, Patthey-Vuadens O, Vuagniaux G, Ruegg UT. Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. British Journal of Pharmacology. 2009;155:574–584. doi: 10.1038/bjp.2008.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ascah A, Khairallah M, Daussin F, Bourcier-Lucas C, Godin R, Allen BG, et al. Stress-induced opening of the permeability transition pore in the dystrophin-deficient heart is attenuated by acute treatment with sildenafil. Am J Physiol Heart Circ Physiol. 2011;300:H144–H153. doi: 10.1152/ajpheart.00522.2010. [DOI] [PubMed] [Google Scholar]
  • 23.Percival JM, Siegel MP, Knowels G, Marcinek DJ. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. Hum Mol Genet. 2012;22:153–167. doi: 10.1093/hmg/dds415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Poláková E, Shirokova N. Abnormal sodium handling and mitochondrial metabolism in cardiac dystrophy. Biophys J. 2011;100:81a. [Google Scholar]
  • 25.Fanchaouy M, Polakova E, Jung C, Ogrodnik J, Shirokova N, Niggli E. Pathways of abnormal stress-induced Ca2+ influx into dystrophic mdx cardiomyocytes. Cell Calcium. 2009;46:114–121. doi: 10.1016/j.ceca.2009.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jornot L, Maechler P, Wollheim CB, Junod AF. Reactive oxygen metabolites increase mitochondrial calcium in endothelial cells: implication of the Ca2+/Na+ exchanger. J Cell Sci. 1999;112(Pt 7):1013–1022. doi: 10.1242/jcs.112.7.1013. [DOI] [PubMed] [Google Scholar]
  • 27.Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K, et al. PINK1-Associated Parkinson’s Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death. Molecular Cell. 2009;33:627–638. doi: 10.1016/j.molcel.2009.02.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Garciarena CD, Youm JB, Swietach P, Vaughan-Jones RD. H+-activated Na+ influx in the ventricular myocyte couples Ca2+-signalling to intracellular pH. J Mol Cell Cardiol. 2013;61:51–59. doi: 10.1016/j.yjmcc.2013.04.008. [DOI] [PubMed] [Google Scholar]
  • 29.Erickson JR, Joiner MLA, Guan X, Kutschke W, Yang J, Oddis CV, et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell. 2008;133:462–474. doi: 10.1016/j.cell.2008.02.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Shirokova N, Kang C, Fernandez-Tenorio M, Wang W, Wang Q, Wehrens XHT, et al. Oxidative stress and Ca2+ release events in mouse cardiomyocytes. Biophys J. 2014;107:2815–2827. doi: 10.1016/j.bpj.2014.10.054. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 31.Weiss JN. Role of the Mitochondrial Permeability Transition in Myocardial Disease. Circ Res. 2003;93:292–301. doi: 10.1161/01.RES.0000087542.26971.D4. [DOI] [PubMed] [Google Scholar]
  • 32.Ruegg UT, Nicolas-Métral V, Challet C, Bernard-Hélary K, Dorchies OM, Wagner S, et al. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul Disord. 2002;12(Suppl 1):S155–61. doi: 10.1016/s0960-8966(02)00095-0. [DOI] [PubMed] [Google Scholar]
  • 33.Burelle Y, Khairallah M, Ascah A, Allen BG, Deschepper CF, Petrof BJ, et al. Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart. J Mol Cell Cardiol. 2010;48:310–321. doi: 10.1016/j.yjmcc.2009.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med. 2008;14:442–447. doi: 10.1038/nm1736. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES